Sky Century Investment (SKYI) Other Non Operating Income (2024 - 2025)

Sky Century Investment's (SKYI) quarterly Other Non Operating Income came in at -$81.0 in Q1 2025, up 84.21% on a QoQ basis from -$513.0 in Q4 2024.

Sky Century Investment (SKYI) Other Non Operating Income (2024 - 2025) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Other Non Operating Income data on file, last reported at -$81.0 in Q1 2025.

On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$81.0 in Q1 2025; TTM through Nov 2025 was -$81.0, a 84.21% increase from a year earlier, with the FY2025 full-year figure at -$594.0, changed N/A from the prior year.
Other Non Operating Income for Q1 2025 stood at -$81.0, up from -$513.0 in the prior quarter.
Over the last five years, Other Non Operating Income for SKYI reached as high as $12000.0 in Q2 2024 and fell as low as -$12000.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	89.86 Bn	88.00 Bn	-
2	Teva Pharmaceutical Industries	35.84 Bn	32.10 Bn	1.97 Bn
3	Zoetis	32.70 Bn	30.76 Bn	1.62 Bn
4	Takeda Pharmaceutical	27.73 Bn	23.67 Bn	4.39 Bn
5	United Therapeutics	23.16 Bn	21.01 Bn	648.10 Mn
6	RedHill Biopharma	21.80 Bn	21.80 Bn	-
7	Viatris	20.18 Bn	18.37 Bn	1.16 Bn
8	Neurocrine Biosciences	17.82 Bn	16.50 Bn	800.70 Mn
9	Elanco Animal Health	12.64 Bn	12.21 Bn	785.00 Mn
10	Sky Century Investment	1.06 Mn	1.06 Mn	26,045.00

Download Data